Blockchain Registration Transaction Record

Alcanza Clinical Research Acquires CNS Healthcare, Expanding Neuroscience Capabilities

Alcanza Clinical Research acquires CNS Healthcare, expanding its clinical trial network in neuroscience and behavioral health. The merger boosts inclusive research access for diverse communities.

This acquisition matters because it directly expands access to clinical trials for under-represented communities, particularly in neuroscience and behavioral health. By combining Alcanza's inclusive mission with CNS Healthcare's 30-year expertise, more patients—especially those from diverse backgrounds—will have opportunities to participate in studies for life-changing treatments. This move accelerates medical progress while ensuring that clinical research reflects the real-world population, ultimately leading to more effective and equitable healthcare solutions.